Schedule 13D ownership disclosure

ACADIA Pharmaceuticals Inc

Security class unavailable · CUSIP: 004225108

Event date: 2019-09-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
41,016,086
Percent of class
27.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-045483
Form type
SC 13D/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
Sep 20, 2019
Reporting period
Sep 17, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub